Immune Disease Institute is categorized under Research Institute in Boston, MA and active since 2004.
Immune Disease Institute was established in 2004, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Timothy Springer at the company’s single location by writing to 200 Longwood Avenue Room 250, Boston, Massachusetts MA 02115 or by phoning (715) 795-2424. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immune Disease Institute |
| Contact Person: | Timothy Springer |
| Address: | 200 Longwood Avenue Room 250, Boston, Massachusetts 02115 |
| Phone Number: | (715) 795-2424 |
| Website Address: | idi.harvard.edu |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research Institute |
| SIC Code: | 8733 |
| NAICS Code: | 541712 |
| Share This Business: |
Immune Disease Institute was started in 2004 to provide professional Research Institute under the SIC code 8733 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Timothy Springer for inquiries that concern Immune Disease Institute by calling the company number (715) 795-2424, as your correspondence is most welcome. Additionally, the physical location of the single location of Immune Disease Institute can be found at the coordinates 42.336356,-71.101787 as well as the street address 200 Longwood Avenue Room 250 in Boston, Massachusetts 02115.
For its online presence, you may visit Immune Disease Institute’s website at idi.harvard.edu and engage with its social media outlets through on Twitter and on Facebook.